Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
Edwards, S. M.; Evans, D. G. R.; Hope, Q.; Norman, A. R.; Barbachano, Y.; Bullock, S.; Kote-Jarai, Z.; Meitz, J.; Falconer, A.; Osin, P.; Fisher, C.; Guy, M.; Jhavar, S. G.; Hall, A. L.; O'Brien, L. T.; Gehr-Swain, B. N.; Wilkinson, R. A.; Forrest, M. S.; Dearnaley, D. P.; Ardern-Jones, A. T.; British Journal of Cancer, 2010, vol. 103, issue 6, p 918, ISSN 00070920. ISBN 00070920.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef